Skip to main content

Table 1 KRAS mutations examined samples

From: KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay

mutation

amino acid

n

%

GGT → GAT

gly12 → asp12

24

40

GGT → TGT

gly12 → cys12

8

13

GGT → GTT

gly12 → val12

14

23

GGT → GCT

gly12 → ala12

4

7

GGT → CGT

gly12 → arg12

2

3

GGC → GAC

gly13 → asp13

4

7

GGC → TGC

gly13 → cys13

1

2

GGT → GCT/GAT

gly12 → ala12/asp12

2

3

GGT → GTT/GAT

gly12 → val12/asp12

1

2

 

total

60

100